Prognostic Impact of Biologically Equivalent Dose in Stereotactic Body Radiation Therapy for Renal Cancer.

[1]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[2]  E. B. Butler,et al.  DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma , 2021, Advances in Radiation Oncology.

[3]  G. MacLennan,et al.  Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  K. Hess,et al.  Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation , 2020, Advances in radiation oncology.

[5]  I. Kaplan,et al.  The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. , 2019, European urology focus.

[6]  L. Livi,et al.  Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature. , 2018, Critical reviews in oncology/hematology.

[7]  V. Khoo,et al.  TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II , 2018, BMC Cancer.

[8]  G. Bauman,et al.  A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma , 2018, Radiation oncology.

[9]  E. B. Butler,et al.  Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA. , 2018, Future oncology.

[10]  I. Kaplan,et al.  Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) , 2018, Cancer.

[11]  B. Slotman,et al.  Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach , 2017, Nature Reviews Urology.

[12]  P. Cheung,et al.  Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[13]  N. Lawrentschuk,et al.  Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  H. Onishi,et al.  Consensus statement Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma , 2016 .

[15]  M. Schluchter,et al.  Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  N. Hardcastle,et al.  Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99mTc-DMSA SPECT/CT , 2014, Radiation oncology.

[17]  E. B. Butler,et al.  Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for “radioresistant” renal cell carcinoma (RCC) , 2014, Journal of Radiation Oncology.

[18]  I. Kaplan,et al.  A Phase 1 Dose-Escalation Study of Robotic Radiosurgery in Inoperable Primary Renal Cell Carcinoma , 2013 .

[19]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[20]  I. Lax,et al.  Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney , 2008, Acta oncologica.

[21]  H. Blomgren,et al.  A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma , 2006, Acta oncologica.

[22]  B. Wessels,et al.  Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in Vitro and in Vivo in human renal cell carcinoma xenografts , 1997, Cancer.

[23]  M. Zelefsky,et al.  Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.